GP-Act III Acquisition Corp. $GPAT Shares Sold by OCONNOR A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS LLC

Posted by Geri Gentry on Jun 20th, 2026

OCONNOR A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS LLC lowered its position in shares of GP-Act III Acquisition Corp. (NASDAQ:GPAT – Free Report) by 28.6% in the 4th quarter, Holdings Channel reports. The fund owned 250,000 shares of the company’s stock after selling 100,000 shares during the period. OCONNOR A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS LLC’s holdings in GP-Act III Acquisition were worth $2,675,000 as of its most recent filing with the SEC.

A number of other large investors have also modified their holdings of GPAT. JPMorgan Chase & Co. acquired a new stake in GP-Act III Acquisition in the 2nd quarter valued at approximately $2,377,000. Shaolin Capital Management LLC acquired a new position in GP-Act III Acquisition during the 2nd quarter valued at about $1,055,000. TENOR CAPITAL MANAGEMENT Co. L.P. bought a new stake in shares of GP-Act III Acquisition during the 2nd quarter worth about $7,800,000. Radcliffe Capital Management L.P. bought a new stake in shares of GP-Act III Acquisition during the 2nd quarter worth about $1,559,000. Finally, Longfellow Investment Management Co. LLC acquired a new stake in shares of GP-Act III Acquisition in the 3rd quarter worth approximately $83,000.

Analyst Ratings Changes

Separately, Weiss Ratings reiterated a “sell (d)” rating on shares of GP-Act III Acquisition in a report on Tuesday, April 21st. One research analyst has rated the stock with a Sell rating, Based on data from MarketBeat, GP-Act III Acquisition currently has a consensus rating of “Sell”.

Check Out Our Latest Analysis on GPAT

GP-Act III Acquisition Stock Performance

NASDAQ:GPAT opened at $10.88 on Friday. GP-Act III Acquisition Corp. has a twelve month low of $10.50 and a twelve month high of $12.00. The company has a 50-day moving average of $10.88 and a 200-day moving average of $10.79.

GP-Act III Acquisition (NASDAQ:GPAT – Get Free Report) last released its earnings results on Thursday, May 14th. The company reported $0.06 EPS for the quarter.

GP-Act III Acquisition Profile

(Free Report)

GP-Act III Acquisition Corp is a special purpose acquisition company organized as a Delaware corporation that completed its initial public offering in 2021. As a blank-check company, it has no commercial operations of its own and was formed to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses.

The company’s primary business activity is to identify and acquire a target company in sectors such as technology, business services, healthcare or other high-growth industries.